Unknown

Dataset Information

0

Modeling primary ovarian insufficiency-associated loci in C. elegans identifies novel pathogenic allele of MSH5.


ABSTRACT:

Purpose

In women under the age of 40, primary ovarian insufficiency (POI) is a devastating diagnosis with significant prevalence of 1-4% (Rajkovic and Pangas, Semin Reprod Med. 35(3):231-40, 2017). POI is characterized by amenorrhea with elevated levels of follicle stimulating hormone (FSH) and reduced estrogen levels, mimicking the menopausal state. Genetic determinants account for just over 10% of POI cases, yet determining whether particular single nucleotide polymorphisms (SNPs) are pathogenic is challenging.

Methods

We performed exome sequencing on a cohort of women with POI. CRISPR mutagenesis was employed to create a mutation in a conserved amino acid in the nematode protein. Functional relevance was assessed by analysis of bivalents and aberrant DNA morphologies in diakinesis nuclei.

Results

We identified a nonsynonymous c.C1051G; p.R351G variant, in a conserved region of the MSH5 protein. Mutation of this conserved amino acid in the C. elegans homolog, msh-5, revealed defective crossover outcomes in the homozygous and hemizygous states.

Conclusions

These studies further implicate MSH5 as a POI gene and c.C1051G; p.R351G variant as likely playing a functional role in mammalian meiosis. This approach also highlights the ability of model organisms, such as C. elegans, to rapidly and inexpensively identify alleles of interest for further studies in mammalian models.

SUBMITTER: Macaisne N 

PROVIDER: S-EPMC9174368 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modeling primary ovarian insufficiency-associated loci in C. elegans identifies novel pathogenic allele of MSH5.

Macaisne Nicolas N   Touzon Maria Sol MS   Rajkovic Aleksander A   Yanowitz Judith L JL  

Journal of assisted reproduction and genetics 20220418 6


<h4>Purpose</h4>In women under the age of 40, primary ovarian insufficiency (POI) is a devastating diagnosis with significant prevalence of 1-4% (Rajkovic and Pangas, Semin Reprod Med. 35(3):231-40, 2017). POI is characterized by amenorrhea with elevated levels of follicle stimulating hormone (FSH) and reduced estrogen levels, mimicking the menopausal state. Genetic determinants account for just over 10% of POI cases, yet determining whether particular single nucleotide polymorphisms (SNPs) are  ...[more]

Similar Datasets

| S-EPMC5393145 | biostudies-literature
| S-EPMC9113820 | biostudies-literature
| S-EPMC7612377 | biostudies-literature
| S-EPMC8983136 | biostudies-literature
| S-EPMC2762081 | biostudies-literature
| S-EPMC9941050 | biostudies-literature
| S-EPMC6760336 | biostudies-literature
| S-EPMC7192606 | biostudies-literature
| S-EPMC7477642 | biostudies-literature
| S-EPMC4250468 | biostudies-literature